Thomas Emmanuel

Arhus, Denmark

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

p75NTR and psoriasis: a new inflammatory pathway?

p75NTR and psoriasis: a new inflammatory pathway?

Journal: The British journal of dermatology

Published: May 11, 2026

Markedly improved disease control in Darier disease (ATP2A2-nonsyndromic epidermal differentiation disorder) with ustekinumab versus other biologics: a case series.

Markedly improved disease control in Darier disease (ATP2A2-nonsyndromic epidermal differentiation disorder) with ustekinumab versus other biologics: a case series.

Journal: Skin health and disease

Published: April 20, 2026

IL-17 Cytokines Induce IκBζ in Dermal Fibroblasts to Promote Pro-Inflammatory Gene Expression in Psoriasis.

IL-17 Cytokines Induce IκBζ in Dermal Fibroblasts to Promote Pro-Inflammatory Gene Expression in Psoriasis.

Journal: International journal of molecular sciences

Published: December 11, 2025

Microvascular alterations in nonlesional psoriatic skin versus healthy control skin: insights from optical coherence tomography angiography in psoriasis and atopic dermatitis.

Microvascular alterations in nonlesional psoriatic skin versus healthy control skin: insights from optical coherence tomography angiography in psoriasis and atopic dermatitis.

Journal: Skin health and disease

Published: October 12, 2025

Spatial transcriptomic profiling reveals body site-specific inflammatory differences in psoriasis lesions.

Spatial transcriptomic profiling reveals body site-specific inflammatory differences in psoriasis lesions.

Journal: Frontiers in immunology

Published: September 16, 2025

Oral Roflumilast Suppresses Proinflammatory Cytokine Signaling and Reduces CD4+ T-Cell and Neutrophil Infiltration in Psoriasis.

Oral Roflumilast Suppresses Proinflammatory Cytokine Signaling and Reduces CD4+ T-Cell and Neutrophil Infiltration in Psoriasis.

Journal: The Journal of investigative dermatology

Published: December 16, 2024

Early Neutrophil Activation in Psoriatic Skin at Relapse Following Dead Sea Climatotherapy.

Early Neutrophil Activation in Psoriatic Skin at Relapse Following Dead Sea Climatotherapy.

Journal: Experimental dermatology

Published: December 04, 2024

Association of inflammatory skin biomarkers with clinical response in RGRN-305-treated patients with hidradenitis suppurativa.

Association of inflammatory skin biomarkers with clinical response in RGRN-305-treated patients with hidradenitis suppurativa.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: July 01, 2024

Secukinumab and Dead Sea Climatotherapy Impact Resolved Psoriasis Skin Differently Potentially Affecting Disease Memory.

Secukinumab and Dead Sea Climatotherapy Impact Resolved Psoriasis Skin Differently Potentially Affecting Disease Memory.

Journal: International journal of molecular sciences

Published: May 02, 2024

RUNX2 as a novel biomarker for early identification of patients progressing to advanced-stage mycosis fungoides.

RUNX2 as a novel biomarker for early identification of patients progressing to advanced-stage mycosis fungoides.

Journal: Frontiers in oncology

Published: April 22, 2024

Efficacy and Safety of the Heat Shock Protein 90 Inhibitor RGRN-305 in Hidradenitis Suppurativa: A Parallel-Design Double-Blind Trial.

Efficacy and Safety of the Heat Shock Protein 90 Inhibitor RGRN-305 in Hidradenitis Suppurativa: A Parallel-Design Double-Blind Trial.

Journal: JAMA dermatology

Published: December 06, 2023

ERAP1 and ERAP2 gene variants as potential clinical biomarkers of anti-interleukin-17A response in psoriasis vulgaris.

ERAP1 and ERAP2 gene variants as potential clinical biomarkers of anti-interleukin-17A response in psoriasis vulgaris.

Journal: Clinical and experimental dermatology

Published: July 04, 2023

Showing 1-12 of 24

Last Updated: 09/26/2026